213 related articles for article (PubMed ID: 26748974)
1. High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.
Itani S; Arabi A; Harb D; Hamzeh D; Kibbi AG
Int J Dermatol; 2016 Apr; 55(4):390-5. PubMed ID: 26748974
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome in Moroccan patients with psoriasis.
Meziane M; Kelati A; Najdi A; Berraho A; Nejjari C; Mernissi FZ
Int J Dermatol; 2016 Apr; 55(4):396-400. PubMed ID: 26712557
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.
Irimie M; Oanţă A; Irimie CA; Fekete LG; Minea DI; Pascu A
Acta Dermatovenerol Croat; 2015; 23(1):28-35. PubMed ID: 25969910
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities associated with psoriasis: an experience from the Middle East.
Al-Mutairi N; Al-Farag S; Al-Mutairi A; Al-Shiltawy M
J Dermatol; 2010 Feb; 37(2):146-55. PubMed ID: 20175849
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
7. A study of cardio-metabolic risk profile in patients with psoriasis.
Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in untreated patients with psoriasis: case-control study.
Damevska K; Neloska L; Gocev G; Mihova M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1169-75. PubMed ID: 24267013
[TBL] [Abstract][Full Text] [Related]
9. Erectile dysfunction in patients with psoriasis: potential impact of the metabolic syndrome.
Tasliyurt T; Bilir Y; Sahin S; Seckin HY; Kaya SU; Sivgin H; Demir AK; Erdemir F
Eur Rev Med Pharmacol Sci; 2014; 18(4):581-6. PubMed ID: 24610625
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the chosen parameters of metabolic status in patients with psoriasis].
Kacalak-Rzepka A; Kiedrowicz M; Maleszka R
Ann Acad Med Stetin; 2013; 59(2):12-7. PubMed ID: 25026745
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital.
Topić I; Simić D
Acta Clin Croat; 2013 Mar; 52(1):53-8. PubMed ID: 23837273
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing cardiometabolic risk profile in patients with psoriasis.
Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cardiovascular risk factors in patients with psoriasis.
Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
[TBL] [Abstract][Full Text] [Related]
14. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
Phan C; Sigal ML; Lhafa M; Barthélémy H; Maccari F; Estève E; Reguiai Z; Perrot JL; Chaby G; Maillard H; Bégon E; Alexandre M; Toussaint P; Bastien-Jacquin M; Bravard P; Sauque E; de Quatrebarbes J; Pfister P; Beauchet A; Mahé E;
Ann Dermatol Venereol; 2016 Apr; 143(4):264-74. PubMed ID: 26969480
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular risk profile of patients with psoriasis].
Di Lisi D; Macaione F; Corrado E; Bonura F; Novo G; Peritore A; Meschisi M; Cuttitta F; Bongiorno MR; Novo S
Recenti Prog Med; 2013 Mar; 104(3):102-5. PubMed ID: 23548953
[TBL] [Abstract][Full Text] [Related]
16. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and psoriasis: a study in 97 patients.
Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
[TBL] [Abstract][Full Text] [Related]
18. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis.
Arias-Santiago S; Orgaz-Molina J; Castellote-Caballero L; Arrabal-Polo MÁ; García-Rodriguez S; Perandrés-López R; Ruiz JC; Naranjo-Sintes R; Zubiaur M; Sancho J; Buendía-Eisman A
Eur J Dermatol; 2012; 22(3):337-44. PubMed ID: 22503884
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis and comorbidities in a southern Brazilian population: a case-control study.
Menegon DB; Pereira AG; Camerin AC; Cestari T
Int J Dermatol; 2014 Nov; 53(11):e518-25. PubMed ID: 25070669
[TBL] [Abstract][Full Text] [Related]
20. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
Papp K; Poulin Y; Vieira A
J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
